<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02794376</url>
  </required_header>
  <id_info>
    <org_study_id>11626</org_study_id>
    <nct_id>NCT02794376</nct_id>
  </id_info>
  <brief_title>Mindfulness for Irritable Bowel Syndrome</brief_title>
  <acronym>MIBS</acronym>
  <official_title>Mindfulness for Irritable Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oxford</source>
  <brief_summary>
    <textblock>
      This study investigates the effectiveness of a 6 week mindfulness intervention in reducing
      symptoms of Irritable Bowel Syndrome (IBS). All Participants will receive treatment.
      Participants will be randomly allocated to an immediate treatment group and a waiting list
      control group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 14, 2016</start_date>
  <completion_date type="Actual">July 10, 2017</completion_date>
  <primary_completion_date type="Actual">July 10, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in IBS symptom Severity (GSRS - IBS)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in IBS quality of Life (IBS-QOL)</measure>
    <time_frame>Baseline and Post Intervention Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Psychological Distress (DASS)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Positive and Negative Emotions (PANAS)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in IBS catastrophizing (GI-Cognitions Questionniare)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Visceral Anxiety Sensitivity (VSI)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Mindfulness (FFMQ-short)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Attentional Control (ANT)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Behavioural Computer-based task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Illness Identification (IAT)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Behavioural Computer-based task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Shame Identification (IAT)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Behavioural Computer-based task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Attention to Health Threat (Dot-probe)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Behavioural Computer-based task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Shame Association (SRET)</measure>
    <time_frame>Baseline and Post Intervention (within the first three weeks of completion or the intervention), Mid-Intervention (after 2 weeks of the start of the intervention)</time_frame>
    <description>Behavioural Computer-based task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in IBS symptom Severity (GSRS - IBS) at Follow up</measure>
    <time_frame>Baseline, Follow up (one month after the post assessment)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in IBS quality of Life (IBS-QOL)</measure>
    <time_frame>Baseline, (Follow up one month after the post assessment)</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline levels of Social Anxiety (SIAS-SPS)</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline levels of Alexithymia (TAS-20)</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline levels of Somatosensory Amplification (SSATS)</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline levels of Thought Suppression (WBSI)</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline levels of Rumination (RRS)</measure>
    <time_frame>Baseline</time_frame>
    <description>Self-Report Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Immediate Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness course consisting of six weekly two hour mindfulness sessions plus meditation homework assignments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Treatment Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Waiting period plus Mindfulness course consisting of six weekly two hour mindfulness sessions plus meditation homework assignments after the waiting period has finished.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Based Cognitive Therapy (MBCT)</intervention_name>
    <arm_group_label>Immediate Treatment Group</arm_group_label>
    <arm_group_label>Delayed Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Waiting Period</intervention_name>
    <arm_group_label>Delayed Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant is willing and able to give informed consent for participation in the
             study.

          -  Diagnosed with IBS by Gastroenterologist or General Practioner (GP), meeting Rome III
             criteria for IBS, symptom onset at least 6 months prior to inclusion, discomfort or
             pain at least 2-3 days per month

          -  Participants speaks English fluently or at a native level

          -  Participant has normal or corrected to normal vision

        Exclusion Criteria:

          -  Participant has insufficient manual dexterity for the computerized tasks

          -  Severe Diagnostic and Statistical Manual (DSM) Axis I or II psychiatric disorder
             (diagnosis of dementia, amnesia, delirium, a dissociative disorder, a personality
             disorder, schizophrenia or any other psychotic disorder, a substance-related or
             induced disorder (such as alcoholism), attention deficit hyperactivity disorder
             (ADHD), attention deficit disorder (ADD), primary diagnosis of obsessive compulsive
             disorder (OCD), current suicidality, regular non-suicidal self-injury.

          -  Recent bereavement (within one year)

          -  GI diagnosis other than IBS (IBD, coeliac disease, another FGID)

          -  Pregnancy

          -  No access to the internet

          -  Prior participation in an 8-week mindfulness course (MBSR, MBCT) or any other
             structured mindfulness training. Prior participation in Vipassana meditation courses.
             Regular meditation practice (meditating more than once per month).

          -  Not able or unwilling to commit to amount of practice (sessions and home practice).

          -  Participant is currently enrolled in another IBS treatment study (psychological or
             pharmacological).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2016</study_first_submitted>
  <study_first_submitted_qc>June 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2016</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IBS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

